07 April 1994 00:00 [Source: ICB]
Monsanto's GD Searle pharmaceuticals subsidiary is looking for alliances and 'other related actions' that would provide cost savings, expanded access to new products and a larger market presence, Monsanto chairman and ceo Richard Mahoney told analysts recently. Searle has already revamped its R&D activities to focus rigorously on the most promising product candidates.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|